Published in Gene Therapy Weekly, July 3rd, 1995
IL-12 is a naturally occurring cytokine that is genetically engineered and produced by Genetics Institute Inc. (GI), of Cambridge, Massachusetts. IL-12 has shown promise as a treatment for cancer, AIDS, tuberculosis, and malaria, and was being clinically tested in a trial of kidney cancer patients.
The multicenter study was put on hold June 8, 1995, when two of seventeen patients were hospitalized. According to a news story in Science (June 16, 1995;268(5217):1555), one of the two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.